vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Golden Matrix Group, Inc. (GMGI). Click either name above to swap in a different company.
Golden Matrix Group, Inc. is the larger business by last-quarter revenue ($49.6M vs $44.9M, roughly 1.1× AbCellera Biologics Inc.). AbCellera Biologics Inc. runs the higher net margin — -19.9% vs -179.0%, a 159.0% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs -15.8%). Golden Matrix Group, Inc. produced more free cash flow last quarter ($6.4M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 104.6%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Golden Matrix Group Inc. is a global gaming tech firm that develops and licenses proprietary online gaming platforms, social casino products and interactive solutions. It serves B2B gaming operator clients across North America, Europe and Asia-Pacific, plus runs direct-to-consumer casual gaming properties.
ABCL vs GMGI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $49.6M |
| Net Profit | $-8.9M | $-88.7M |
| Gross Margin | — | 57.5% |
| Operating Margin | -63.7% | -188.3% |
| Net Margin | -19.9% | -179.0% |
| Revenue YoY | 788.4% | -15.8% |
| Net Profit YoY | 73.9% | -4880.1% |
| EPS (diluted) | $-0.03 | $-7.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $49.6M | ||
| Q3 25 | $9.0M | $47.3M | ||
| Q2 25 | $17.1M | $43.2M | ||
| Q1 25 | $4.2M | $42.7M | ||
| Q4 24 | $5.0M | $58.9M | ||
| Q3 24 | $6.5M | $41.0M | ||
| Q2 24 | $7.3M | $39.4M | ||
| Q1 24 | $10.0M | $11.8M |
| Q4 25 | $-8.9M | $-88.7M | ||
| Q3 25 | $-57.1M | $566.0K | ||
| Q2 25 | $-34.7M | $-3.6M | ||
| Q1 25 | $-45.6M | $-231.6K | ||
| Q4 24 | — | $1.9M | ||
| Q3 24 | $-51.1M | $-3.4M | ||
| Q2 24 | $-36.9M | $64.9K | ||
| Q1 24 | $-40.6M | $74.5K |
| Q4 25 | — | 57.5% | ||
| Q3 25 | — | 55.8% | ||
| Q2 25 | — | 56.4% | ||
| Q1 25 | — | 56.6% | ||
| Q4 24 | — | 69.8% | ||
| Q3 24 | — | 54.7% | ||
| Q2 24 | — | 55.0% | ||
| Q1 24 | — | 28.5% |
| Q4 25 | -63.7% | -188.3% | ||
| Q3 25 | -851.8% | -0.8% | ||
| Q2 25 | -290.2% | -5.3% | ||
| Q1 25 | -1479.6% | -0.2% | ||
| Q4 24 | — | 5.6% | ||
| Q3 24 | -1439.4% | -2.4% | ||
| Q2 24 | -1276.2% | 0.3% | ||
| Q1 24 | -551.5% | 2.4% |
| Q4 25 | -19.9% | -179.0% | ||
| Q3 25 | -637.8% | 1.2% | ||
| Q2 25 | -203.3% | -8.3% | ||
| Q1 25 | -1077.2% | -0.5% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | -785.4% | -8.3% | ||
| Q2 24 | -504.3% | 0.2% | ||
| Q1 24 | -408.0% | 0.6% |
| Q4 25 | $-0.03 | $-7.73 | ||
| Q3 25 | $-0.19 | $0.00 | ||
| Q2 25 | $-0.12 | $-0.03 | ||
| Q1 25 | $-0.15 | $0.00 | ||
| Q4 24 | — | $-0.13 | ||
| Q3 24 | $-0.17 | $-0.03 | ||
| Q2 24 | $-0.13 | $0.00 | ||
| Q1 24 | $-0.14 | $0.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $46.5M |
| Total Assets | $1.4B | $118.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | — | ||
| Q3 25 | $83.2M | — | ||
| Q2 25 | $92.4M | — | ||
| Q1 25 | $159.3M | — | ||
| Q4 24 | $156.3M | — | ||
| Q3 24 | $126.6M | — | ||
| Q2 24 | $148.3M | — | ||
| Q1 24 | $123.6M | — |
| Q4 25 | $966.9M | $46.5M | ||
| Q3 25 | $964.0M | $123.5M | ||
| Q2 25 | $1.0B | $121.3M | ||
| Q1 25 | $1.0B | $108.5M | ||
| Q4 24 | $1.1B | $105.1M | ||
| Q3 24 | $1.1B | $94.3M | ||
| Q2 24 | $1.1B | $90.4M | ||
| Q1 24 | $1.1B | $32.1M |
| Q4 25 | $1.4B | $118.1M | ||
| Q3 25 | $1.4B | $209.8M | ||
| Q2 25 | $1.4B | $210.3M | ||
| Q1 25 | $1.3B | $214.0M | ||
| Q4 24 | $1.4B | $213.7M | ||
| Q3 24 | $1.4B | $213.5M | ||
| Q2 24 | $1.4B | $191.5M | ||
| Q1 24 | $1.5B | $37.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $8.2M |
| Free Cash FlowOCF − Capex | $-44.6M | $6.4M |
| FCF MarginFCF / Revenue | -99.4% | 13.0% |
| Capex IntensityCapex / Revenue | 21.9% | 3.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $19.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $8.2M | ||
| Q3 25 | $-52.6M | $7.0M | ||
| Q2 25 | $-32.4M | $2.4M | ||
| Q1 25 | $-11.6M | $7.7M | ||
| Q4 24 | $-108.6M | — | ||
| Q3 24 | $-28.9M | $4.8M | ||
| Q2 24 | $-30.0M | — | ||
| Q1 24 | $-41.7M | $8.2K |
| Q4 25 | $-44.6M | $6.4M | ||
| Q3 25 | $-61.5M | $6.2M | ||
| Q2 25 | $-45.8M | $-89.4K | ||
| Q1 25 | $-22.2M | $6.6M | ||
| Q4 24 | $-187.0M | — | ||
| Q3 24 | $-47.4M | $2.3M | ||
| Q2 24 | $-50.1M | — | ||
| Q1 24 | $-65.8M | $6.7K |
| Q4 25 | -99.4% | 13.0% | ||
| Q3 25 | -687.0% | 13.1% | ||
| Q2 25 | -267.9% | -0.2% | ||
| Q1 25 | -524.0% | 15.5% | ||
| Q4 24 | -3702.8% | — | ||
| Q3 24 | -728.4% | 5.6% | ||
| Q2 24 | -683.8% | — | ||
| Q1 24 | -661.5% | 0.1% |
| Q4 25 | 21.9% | 3.6% | ||
| Q3 25 | 99.7% | 1.8% | ||
| Q2 25 | 78.2% | 5.7% | ||
| Q1 25 | 251.1% | 2.6% | ||
| Q4 24 | 1552.7% | — | ||
| Q3 24 | 284.6% | 6.0% | ||
| Q2 24 | 274.6% | — | ||
| Q1 24 | 242.5% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 12.42× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.11× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCL
Segment breakdown not available.
GMGI
| R Kings And CFAC | $43.8M | 88% |
| Other | $5.8M | 12% |
